Privi Speciality Chemicals Limited (PRIVISCL)
Investors Presentation - Financial and Operation Review for quarter ended June 30,2026.
AI summary
- Q1 FY27 revenue Rs 681.42 Cr +20.01% y-y; EBITDA Rs 167.47 Cr +18.73% y-y; PAT Rs 84.21 Cr +35.97% y-y
- EBITDA margin 24.6%, impacted by 42 bps due to fire loss; margin to normalize on insurance claim
- Expansion projects on track for commercial operations in H2 FY28
- Growth strategy targets Rs 5,000 Cr revenue and Rs 1,000 Cr+ EBITDA by FY29-30 with >20% EBITDA margin
- New products and R&D expected to expand market and deepen customer relationships
- Strong balance sheet and cash flows support future growth
- Strategic merger planned to enhance agility and unlock faster growth
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 PRIVISCL — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add PRIVISCL to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Privi Speciality Chemicals Limited
Important.
The summary above is generated automatically from Privi Speciality Chemicals Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.